Monday, June 15, 2026

North Korea Exhibits Hesitancy in Diplomacy with Key Ally Belarus

North Korea shows hesitance in fully engaging with Belarus, despite diplomatic gestures and potential visits from President Lukashenko.

Revolutionary Long-Lasting Injections: How IVL3003 and IVL3004 are Transforming Dementia and Addiction Treatments

Inventage Lab will present promising results from clinical trials of two long-acting injectables at the 2026 AAN meeting in Chicago.

North Korea Hails Anti-Japanese Resistance Spirit Ahead of Liberation Day

North Korea emphasizes its commitment to education and national pride while addressing Western shifts on Palestinian recognition.

Tag: disease

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Coronary Intravascular Lithotripsy Gains Attention as Safer Alternative for Heavily Calcified Arteries

Kyung Hee University Hospital's cardiology team uses coronary intravascular lithotripsy to treat severe calcified coronary artery disease in elderly patients.

Hand, Foot and Mouth Disease Cases Surge Among Young Children as Summer Outbreak Season Begins

Hand, foot and mouth disease is resurging among young children, with increased cases reported in daycare centers. Parents are concerned.

Daewoong’s Envlo Matches Established SGLT-2 Drugs in Landmark Head-to-Head Diabetes Study

Daewoong Pharmaceutical's Envlo shows promising results in diabetes treatment, comparing favorably to existing SGLT-2 inhibitors in a clinical study.

Mediwhale Expands Global Digital Health Push With New European Certification for AI Retinal Risk Analysis

Mediwhale is advancing in digital healthcare with AI retinal analysis, securing funding, and aiming for IPO to enhance disease risk prediction.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

Seoul St. Mary’s Prof. Jang Ki-yuk Selected as Sole Applied Medicine Researcher in National Leader Program

Prof. Jang Ki-yuk of Seoul St. Mary's Hospital receives $5.2M for cardiovascular disease research, focusing on plaque regression.

IBS Researchers Advance Conditional Gene Editing With Cross-Species Expansion of SCON System

Researchers at IBS expanded the SCON gene knockout technology, enhancing studies in zebrafish and human stem cells for precise gene control.

Seoul St. Mary’s Hospital Launches National Cohort Study on Asymptomatic Tuberculosis

A study on asymptomatic tuberculosis at Seoul St. Mary's Hospital aims to improve diagnosis and treatment, focusing on early intervention.

South Korea Reports No HPAI Cases in Domestic Pets or Livestock After Expanded 2025 Monitoring

No cases of avian influenza were found in pets or livestock in 2025, despite global concerns over mammal infections. Vigilance continues.

Gene Editing Study Suggests New Treatment Path for Rare Krabbe Disease

A study reveals adenine base editing may treat Krabbe disease, offering hope for rare genetic disorders through precise gene correction.

South Korea Raises Ebola Alert and Tightens Quarantine as DR Congo and Uganda Outbreaks Spread

South Korea raises its Ebola alert level to "Attention" amid outbreaks in Congo and Uganda, urging travelers to monitor health closely.

South Korean Team Develops Non-Invasive Device for Early Cardiovascular Risk Screening

South Korean researchers developed the Coronyzer, a non-invasive device predicting cardiovascular health via pulse wave analysis.

Celltrion’s Zymfentra Just Hit a New U.S. Prescription Record and the Growth Looks Serious

Celltrion's Zymfentra treatment saw a 185% surge in U.S. prescriptions, driven by effective marketing and reimbursement strategies.

A Long-Acting Oral Drug? Yuhan’s Latest Trial Update Is Turning Heads

Yuhan Corp's YH35995 shows promising results for Gaucher disease in Phase 1 trial, demonstrating long-lasting efficacy and BBB penetration.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.